ACE Inhibition and AT1 Receptor Blockers: Efficacy and Duration in Hypertension

Heart
doi 10.1136/heart.84.suppl_1.i39
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

AT1 Receptor Blockers Prevent Sympathetic Hyperactivity and Hypertension by Chronic Ouabain and Hypertonic Saline

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2001English

AT1-receptor Blockers: Differences That Matter

Journal of Human Hypertension
Internal Medicine
2002English

AT1. Effect of Pharmacodynamics ACE Polymorphism of Receptor Antagonists.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1997English

Effect of ACE Inhibitors and Β-Blockers on Homocysteine Levels in Essential Hypertension

Journal of Human Hypertension
Internal Medicine
2008English

The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

Drug Safety
ToxicologyPharmacology
2014English

Prevention of Dementia by ACE Inhibitors and Angiotensin Receptor Blockers - Potential but Not Proven

International Journal of Clinical Practice
Medicine
2010English

Isolated Systolic Hypertension in Elderly WKY Is Reversed With L-Arginine and ACE Inhibition

Hypertension
Internal Medicine
2001English

Should ACE Inhibitors and Angiotensin Receptor Blockers Be Withdrawn in the Current Setting of COVID-19 Infection?

Wits Journal of Clinical Medicine
2020English

ACE-inhibitors but Not Endothelin Receptor Blockers Prevent Podocyte Loss in Early Diabetic Nephropathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy